首页    期刊浏览 2024年11月11日 星期一
登录注册

文章基本信息

  • 标题:Targeting a scavenger receptor on tumor-associated macrophages activates tumor cell killing by natural killer cells
  • 本地全文:下载
  • 作者:Silke Eisinger ; Dhifaf Sarhan ; Vanessa F. Boura
  • 期刊名称:Proceedings of the National Academy of Sciences
  • 印刷版ISSN:0027-8424
  • 电子版ISSN:1091-6490
  • 出版年度:2020
  • 卷号:117
  • 期号:50
  • 页码:32005-32016
  • DOI:10.1073/pnas.2015343117
  • 出版社:The National Academy of Sciences of the United States of America
  • 摘要:Tumor-associated macrophages (TAMs) can have protumor properties, including suppressing immune responses, promoting vascularization and, consequently, augmenting tumor progression. To stop TAM-mediated immunosuppression, we use a novel treatment by injecting antibodies specific for scavenger receptor MARCO, which is expressed on a specific subpopulation of TAMs in the tumor. We now report the location of this TAM as well as the pleiotropic mechanism of action of anti-MARCO antibody treatment on tumor progression and further show that this is potentially relevant to humans. Using specific targeting, we observed decreased tumor vascularization, a switch in the metabolic program of MARCO-expressing macrophages, and activation of natural killer (NK) cell killing through TNF-related apoptosis-inducing ligand (TRAIL). This latter activity reverses the effect of melanoma cell-conditioned macrophages in blocking NK activation and synergizes with T cell-directed immunotherapy, such as antibodies to PD-1 or PD-L1, to enhance tumor killing. Our study thus reveals an approach to targeting the immunosuppressive tumor microenvironment with monoclonal antibodies to enhance NK cell activation and NK cell-mediated killing. This can complement existing T cell-directed immunotherapy, providing a promising approach to combinatorial immunotherapy for cancer.
  • 关键词:immunotherapy ; melanoma ; tumor associated macrophages
国家哲学社会科学文献中心版权所有